Skip to main content
SpringerLink
Log in

SGLT2 inhibitor-related diabetic ketoacidosis: Australian cases

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. SGLT2 = sodium-glucose cotransporter-2

  2. This is a temporary condition where the patient's heart muscle becomes suddenly weakened or "stunned".

Reference

  • Meyer EJ, et al. SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications. Diabetes Care : [3 pages], 13 Feb 2018. Available from: URL: https://doi.org/10.2337/dc17-1721

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

SGLT2 inhibitor-related diabetic ketoacidosis: Australian cases. Reactions Weekly 1691, 11 (2018). https://doi.org/10.1007/s40278-018-42266-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-42266-0

Search

Navigation